4//SEC Filing
BALDO LANCE 4
Accession 0001209191-22-018021
CIK 0001478320other
Filed
Mar 9, 7:00 PM ET
Accepted
Mar 10, 6:00 PM ET
Size
5.4 KB
Accession
0001209191-22-018021
Insider Transaction Report
Form 4
BALDO LANCE
Chief Medical Officer
Transactions
- Sale
Common Stock
2022-03-08$11.43/sh−3,350$38,291→ 17,171 total
Footnotes (2)
- [F1]The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 12, 2021.
- [F2]The price reported for this transaction is a weighted-average price. The shares were sold in multiple transactions ranging from $11.28 to 11.65, inclusive. The reporting person undertakes to provide to Adaptive Biotechnologies Corporation, any security holder of Adaptive Biotechnologies Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in any footnotes to this Form 4.
Documents
Issuer
Adaptive Biotechnologies Corp
CIK 0001478320
Entity typeother
Related Parties
1- filerCIK 0001780773
Filing Metadata
- Form type
- 4
- Filed
- Mar 9, 7:00 PM ET
- Accepted
- Mar 10, 6:00 PM ET
- Size
- 5.4 KB